Riccardo Scotto

Naples, 80138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Ethnic Differences in the Presentation Patterns of Type 3 Macular Neovascularization.

Ethnic Differences in the Presentation Patterns of Type 3 Macular Neovascularization.

Journal: Retina (Philadelphia, Pa.)

Published: June 09, 2026

Clinical Outcomes and Predictors of Mortality in Patients with Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Retrospective Cohort Study.

Clinical Outcomes and Predictors of Mortality in Patients with Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Retrospective Cohort Study.

Journal: Antibiotics (Basel, Switzerland)

Published: December 01, 2025

Correction: Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.

Correction: Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.

Journal: Infection

Published: July 10, 2025

Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).

Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).

Journal: BMC infectious diseases

Published: April 29, 2025

Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case-Control Study (SAVALO Study).

Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case-Control Study (SAVALO Study).

Journal: Microorganisms

Published: February 11, 2025

Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study.

Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study.

Journal: Annals of medicine

Published: December 11, 2024

Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study.

Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study.

Journal: Antibiotics (Basel, Switzerland)

Published: September 26, 2024

Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.

Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.

Journal: Infection

Published: September 05, 2024

Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).

Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).

Journal: BMC infectious diseases

Published: June 10, 2024

COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.

COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.

Journal: BMC cancer

Published: January 23, 2024

In Vivo Confocal Microscopy Characterization of Candida parapsilosis Keratitis.

In Vivo Confocal Microscopy Characterization of Candida parapsilosis Keratitis.

Journal: Eye & contact lens

Published: September 26, 2023

Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.

Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.

Journal: Journal of fungi (Basel, Switzerland)

Published: July 08, 2023

Showing 1-12 of 92

Last Updated: 09/26/2026